Agios Pharma (AGIO) Tops Q3 EPS by 6c

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.64), $0.06 better than the analyst estimate of ($1.70). Revenue for the quarter came in at $7.34 million versus the consensus estimate of $7.64 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Piper Sandler Reiterates Overweight Rating on Block Inc. (XYZ)
• Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance